Novartis' acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company's existing allergy portfolio. It comes just a week after Novartis announced it is acquiring ...
BLOOMINGTON, Ind., April 2, 2026 /PRNewswire/ -- How can patients tell when tooth pain has become serious enough to require a root canal? That question is answered in a HelloNation article featuring ...
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of ...
In a study in Immunity, Allen et al. show that senescent lung fibroblasts in aged mice promote inflammaging by supporting a pro-inflammatory, ageing-associated T cell phenotype defined by granzyme K ...
The ongoing global climate crisis is characterized by rising mean water temperatures, thermal stress, ocean acidification, and fluctuating dissolved oxygen ...
Neoadjuvant or perioperative immunotherapy, either alone or in combination with other antineoplastic agents (e.g., chemotherapy), has been shown to improve ...
When combined with immune checkpoint inhibitors, bread coated in attenuated Listeria stimulated a gut immune response and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results